Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
2005 1
2006 3
2007 5
2008 8
2009 35
2010 72
2011 93
2012 113
2013 138
2014 172
2015 196
2016 174
2017 214
2018 223
2019 276
2020 301
2021 375
2022 429
2023 411
2024 151

Text availability

Article attribute

Article type

Publication date

Search Results

2,962 results

Results by year

Filters applied: . Clear all
Page 1
The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022.
Veitch DP, Weiner MW, Miller M, Aisen PS, Ashford MA, Beckett LA, Green RC, Harvey D, Jack CR Jr, Jagust W, Landau SM, Morris JC, Nho KT, Nosheny R, Okonkwo O, Perrin RJ, Petersen RC, Rivera Mindt M, Saykin A, Shaw LM, Toga AW, Tosun D; Alzheimer's Disease Neuroimaging Initiative. Veitch DP, et al. Alzheimers Dement. 2024 Jan;20(1):652-694. doi: 10.1002/alz.13449. Epub 2023 Sep 12. Alzheimers Dement. 2024. PMID: 37698424 Free PMC article. Review.
The Alzheimer's Disease Neuroimaging Initiative (ADNI) aims to improve Alzheimer's disease (AD) clinical trials. Since 2006, ADNI has shared clinical, neuroimaging, and cognitive data, and biofluid samples. ...Biological subtypes were consistently observed. Generali …
The Alzheimer's Disease Neuroimaging Initiative (ADNI) aims to improve Alzheimer's disease (AD) clinical trials. Since 2006, ADNI …
[J-ADNI].
Iwatsubo T. Iwatsubo T. Rinsho Shinkeigaku. 2010 Nov;50(11):935. doi: 10.5692/clinicalneurol.50.935. Rinsho Shinkeigaku. 2010. PMID: 21921517 Japanese. No abstract available.
Assessing and validating reliable change across ADNI protocols.
Hammers DB, Kostadinova R, Unverzagt FW, Apostolova LG; Alzheimer’s Disease Neuroimaging Initiative*. Hammers DB, et al. J Clin Exp Neuropsychol. 2022 Mar;44(2):85-102. doi: 10.1080/13803395.2022.2082386. Epub 2022 Jul 4. J Clin Exp Neuropsychol. 2022. PMID: 35786312 Free PMC article.
The current study sought to develop and cross-validate 12-month standardized regression-based (SRB) equations for the neuropsychological measures commonly administered in the Alzheimer's Disease Neuroimaging Initiative (ADNI) longitudinal study. METHOD: Prediction algorith …
The current study sought to develop and cross-validate 12-month standardized regression-based (SRB) equations for the neuropsychological mea …
Imago Mundi, Imago AD, Imago ADNI.
Villemagne VL, Kim SY, Rowe CC, Iwatsubo T. Villemagne VL, et al. Alzheimers Res Ther. 2014 Aug 29;6(5):62. doi: 10.1186/s13195-014-0062-5. eCollection 2014. Alzheimers Res Ther. 2014. PMID: 25478022 Free PMC article. Review.
Since the launch in 2003 of the Alzheimer's Disease Neuroimaging Initiative (ADNI) in the USA, ever growing, similarly oriented consortia have been organized and assembled around the world. The various accomplishments of ADNI have contributed substantially to a bett …
Since the launch in 2003 of the Alzheimer's Disease Neuroimaging Initiative (ADNI) in the USA, ever growing, similarly oriented conso …
Integrating ADNI results into Alzheimer's disease drug development programs.
Cummings JL. Cummings JL. Neurobiol Aging. 2010 Aug;31(8):1481-92. doi: 10.1016/j.neurobiolaging.2010.03.016. Epub 2010 May 5. Neurobiol Aging. 2010. PMID: 20447734 Free PMC article. Review.
The Alzheimer's Disease Neuroimaging Initiative (ADNI) is providing critical new information on biomarkers in cognitively normal elderly, persons with mild cognitive impairment (MCI), and patients with mild Alzheimer's disease (AD). The data provide insights into the progr …
The Alzheimer's Disease Neuroimaging Initiative (ADNI) is providing critical new information on biomarkers in cognitively normal elde …
Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans.
Saykin AJ, Shen L, Yao X, Kim S, Nho K, Risacher SL, Ramanan VK, Foroud TM, Faber KM, Sarwar N, Munsie LM, Hu X, Soares HD, Potkin SG, Thompson PM, Kauwe JS, Kaddurah-Daouk R, Green RC, Toga AW, Weiner MW; Alzheimer's Disease Neuroimaging Initiative. Saykin AJ, et al. Alzheimers Dement. 2015 Jul;11(7):792-814. doi: 10.1016/j.jalz.2015.05.009. Alzheimers Dement. 2015. PMID: 26194313 Free PMC article. Review.
INTRODUCTION: Genetic data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) have been crucial in advancing the understanding of Alzheimer's disease (AD) pathophysiology. ...To date, APOE genotyping, genome-wide association study (GWAS), and whole exome and whole …
INTRODUCTION: Genetic data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) have been crucial in advancing the understandi …
Biomarkers of Alzheimer's disease in Black and/or African American Alzheimer's Disease Neuroimaging Initiative (ADNI) participants.
Groechel RC, Tripodis Y, Alosco ML, Mez J, Qiao Qiu W, Goldstein L, Budson AE, Kowall NW, Shaw LM, Weiner M, Jack CR Jr, Killiany RJ; Alzheimer’s Disease Neuroimaging Initiative. Groechel RC, et al. Neurobiol Aging. 2023 Nov;131:144-152. doi: 10.1016/j.neurobiolaging.2023.07.021. Epub 2023 Jul 20. Neurobiol Aging. 2023. PMID: 37639768
To obtain a better understanding of biomarker presentation of Alzheimer's disease (AD) in the non-Hispanic White population, this study exclusively examined AD biomarker abnormalities in 85 Black and/or African American participants within the Alzheimer's Disease Neuroimaging Ini …
To obtain a better understanding of biomarker presentation of Alzheimer's disease (AD) in the non-Hispanic White population, this study excl …
Associations of circulating saturated long-chain fatty acids with risk of mild cognitive impairment and Alzheimer's disease in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort.
Fan L, Borenstein AR, Wang S, Nho K, Zhu X, Wen W, Huang X, Mortimer JA, Shrubsole MJ, Dai Q; Alzheimer’s Disease Neuroimaging Initiative. Fan L, et al. EBioMedicine. 2023 Nov;97:104818. doi: 10.1016/j.ebiom.2023.104818. Epub 2023 Oct 2. EBioMedicine. 2023. PMID: 37793213 Free PMC article.
This study aimed to examine whether circulating saturated LCFAs are associated with both risks of incident MCI from cognitively normal (CN) participants and incident AD progressed from MCI in the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. METHODS: We conduc …
This study aimed to examine whether circulating saturated LCFAs are associated with both risks of incident MCI from cognitively normal (CN) …
2,962 results